For representatives of the dietary supplement industry in Washington D.C., the past year has been a virtual roller coaster ride filled with high and low points, depending on one’s perspective. New bioterrorism regulations, pending adoption of good manufacturing practices (GMPs) by the
(FDA), a federal ban on ephedra and a Presidential mandate to outlaw steroids are just a few of the measures impacting the supplement industry. Proposed Congressional bills would impose more new require
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.